Given its role in development and cancer, Cripto has significant clinical implications. It is being studied as a potential biomarker for cancer diagnosis and prognosis. Additionally, targeting Cripto with specific inhibitors or antibodies is being explored as a therapeutic strategy in oncology. In regenerative medicine, Cripto's ability to modulate stem cell behavior is of great interest for tissue engineering and repair.
